Impact of biologics and small molecules for inflammatory bowel disease on COVID‐19‐related hospitalization and mortality: A systematic review and meta‐analysis

por Alrashed, Fatema, Alasfour, Hajer, Shehab, Mohammad
Publicado 2022

COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study

por Shehab, Mohammad, Alrashed, Fatema, Alfadhli, Ahmad
Publicado 2022

The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction

por Alrashed, Fatema, Almutairi, Najlaa, Shehab, Mohammad
Publicado 2022

Effectiveness of vedolizumab and ustekinumab as second biologic agent in achieving target outcomes in tumor necrosis factor antagonists experienced patients with inflammatory bowel...

por Alrashed, Fatema, Abdullah, Israa, Alfadhli, Ahmad, Shehab, Mohammad
Publicado 2023

Biologic Therapies for the Treatment of Post-ileal Pouch Anal Anastomosis Surgery Chronic Inflammatory Disorders: Systematic Review and Meta-analysis

por Shehab, Mohammad, Alrashed, Fatema, Charabaty, Aline, Bessissow, Talat
Publicado 2022

Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis

por Shehab, Mohammad, Alrashed, Fatema, Shuaibi, Sameera, Alajmi, Dhuha, Barkun, Alan
Publicado 2021

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis

por Alrashed, Fatema, Battat, Robert, Abdullah, Israa, Charabaty, Aline, Shehab, Mohammad
Publicado 2021

Impact of tumor necrosis factor antagonist combination and anti-integrin therapies on body mass index in inflammatory bowel disease: A cross-sectional study

por Shehab, Mohammad, Alali, Ali, Al-Hindawi, Ahmed, Alsayegh, Abdulwahab, Aldallal, Usama, Abdullah, Israa, Albaghli, Abbas, Alrashed, Fatema, Alfadhli, Ahmad, Bessissow, Talat
Publicado 2023

Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-Term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective Study

por Shehab, Mohammad, Alrashed, Fatema, Abdullah, Israa, Alfadhli, Ahmad, Ali, Hamad, Abu-Farha, Mohamed, Channanath, Arshad Mohamed, Abubaker, Jehad Ahmed, Al-Mulla, Fahd
Publicado 2022

Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study

por Shehab, Mohammad, Abu-Farha, Mohamed, Alrashed, Fatema, Alfadhli, Ahmad, Alotaibi, Khazna, Alsahli, Abdullah, Alphonse Thanaraj, Thangavel, Channanath, Arshad, Ali, Hamad, Abubaker, Jehad, Almulla, Fahd
Publicado 2021

Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies

por Shehab, Mohammad, Alrashed, Fatema, Alfadhli, Ahmad, Alotaibi, Khazna, Alsahli, Abdullah, Mohammad, Hussain, Cherian, Preethi, Al-Khairi, Irina, Alphonse Thanaraj, Thangavel, Channanath, Arshad, Ali, Hamad, Abu-Farha, Mohamed, Abubaker, Jehad, Al-Mulla, Fahd
Publicado 2021

Immunogenicity of BNT162b2 Vaccine Booster Dose in Patients With Inflammatory Bowel Disease Receiving Infliximab Combination Therapy: A Prospective Observational Study

por Shehab, Mohammad, Alrashed, Fatema, Alfadhli, Ahmad, Alsayegh, Abdulwahab, Aldallal, Usama, Alsayegh, Mariam, Cherian, Preethi, Alkhair, Irina, Thanaraj, Thangavel Alphonse, Channanath, Arshad, Dashti, Ali A., Albanaw, Anwar, Ali, Hamad, Abu-Farha, Mohamed, Abubaker, Jehad, Al-Mulla, Fahd
Publicado 2022